Table 2.
Antibiotic | Abr. | CFM.yannicii | M.yannicii | M.trichothecenolyticum | M.flavescens | M.hominis |
---|---|---|---|---|---|---|
Fosfomycin |
FOS50 |
7/R |
7/R |
7/R |
7/R |
7/R |
Chloramphenicol |
C30 |
S |
S |
S |
16/S |
24/S |
Doxycycline |
D30 |
S |
S |
S |
7/R |
7/R |
Erythromycin |
E15 |
7/R |
S |
S |
7/R |
34/S |
Vancomycin |
VA |
S |
S |
S |
20/S |
14/R |
Clindamycin |
CM5 |
8/R |
S |
12/R |
7/R |
7/R |
Oxacillin |
OX5 |
20/S |
S |
7/R |
7/R |
7/R |
Rifampicin |
RA30 |
S |
S |
24/S |
28/S |
20/S |
Colistin |
CT50 |
30/S |
20/S |
20/S |
12/R |
10/R |
Gentamicin |
GM15 |
12/R |
10/R |
14/R |
7/R |
10/R |
Tobramycin |
TM10 |
7/R |
7/R |
7/R |
7/R |
7/R |
Ciprofloxacine |
CIP5 |
7/R |
15/R |
12/R |
7/R |
20/S |
Ofloxacine |
OFX5 |
7/R |
11/R |
10/R |
7/R |
7/R |
Trimethoprim-Sulfamethoxazole |
SXT |
7/R |
31/S |
24/S |
S |
S |
Amoxicillin |
AX25 |
S |
S |
S |
S |
20/S |
Imipenem |
IMP10 |
S |
S |
S |
S |
S |
Ceftazidime |
CAZ30 |
S |
7/R |
7/R |
7/R |
16/S |
Ticarcilline |
TIC75 |
S |
S |
7/R |
7/R |
12/R |
Cefoxitin |
FOX30 |
S |
20/S |
7/R |
16/S |
26/S |
Ceftriaxone |
CRO30 |
S |
S |
24/S |
7/R |
S |
Amoxicillin-Clavulinic acid | AMC30 | S | S | S | S | S |
Antibiotic susceptibility testing of CF clinical M. yannicii PS01 isolate and M. yannicii DSM 23203, M. flavescens, M. trichothecenolyticum and M. hominis reference strains.
S sensitive, R resistant, Numbers given in mm.